Product correctly added to cart.

Azd-PEG2-pfp
View 3D

Biosynth logo

Azd-PEG2-pfp

CAS: 1807537-41-2

Ref. 3D-HXC53741

10mgDiscontinued
25mgDiscontinued
50mgDiscontinued
100mgDiscontinued
250mgDiscontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .


Product Information

Name:
Azd-PEG2-pfp
Synonyms:
  • Propanoic acid, 3-[2-[3-oxo-3-[[4-[3-oxo-3-(2-oxo-1-azetidinyl)propyl]phenyl]amino]propoxy]ethoxy]-, 2,3,4,5,6-pentafluorophenyl ester
  • 2,3,4,5,6-Pentafluorophenyl 3-[2-[3-oxo-3-[[4-[3-oxo-3-(2-oxo-1-azetidinyl)propyl]phenyl]amino]propoxy]ethoxy]propanoate
  • AZD-PEG2-PFP
Description:

Azd-PEG2-pfp is a PEG fluorine compound that is used in the process of pegylation. Pegylation involves attaching polyethylene glycol (PEG) molecules to a drug or therapeutic protein, which can improve its stability and prolong its circulation time in the body. Azd-PEG2-pfp contains an azide group, which allows for further modification and conjugation with other molecules. This compound is specifically designed for use in the synthesis of fluorophenyl PEG, a halogenated PEG derivative that can be used in various applications such as drug delivery systems and bioconjugation. With its unique properties, Azd-PEG2-pfp offers versatility and flexibility in the development of PEG-based products.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
572.5 g/mol
Formula:
C26H25F5N2O7
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Inquiry about discontinued product: 3D-HXC53741 Azd-PEG2-pfp

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".